2013-05-18@09:34:53 ET
Australia Patent: Application for 'Methods for preparing anti-viral nucleotide analogs' Lapses (ABW)
|
2013-05-17@16:05:00 ET
Gilead Sciences to Present at the 2013 UBS Global Healthcare Conference on Monday, May 20 (BIZ)
|
2013-05-17@12:43:26 ET
Analyst Moves: NOC, GM, GILD (MNV)
|
2013-05-16@10:16:00 ET
Scleroderma Experts from Johns Hopkins, Northwestern and Stanford to Explain Symptoms and Treatment Options (PRN)
|
2013-05-15@18:30:00 ET
Gilead Announces Response Data from Phase 2 Study of Idelalisib for Previously Untreated Chronic Lymphocytic Leukemia (BIZ)
|
2013-05-15@08:48:14 ET
Gilead Sciences (GILD) Showing Bullish Technicals But Could Break Through $57.51 Resistance (FBM)
|
2013-05-15@06:40:52 ET
Form 4: Update Filing for Gilead Sciences Inc (GILD) (VKR)
|
2013-05-15@06:40:42 ET
Form 4: Update Filing for Gilead Sciences Inc (GILD) (VKR)
|
2013-05-15@06:40:31 ET
Form 4: Update Filing for Gilead Sciences Inc (GILD) (VKR)
|
2013-05-15@06:40:21 ET
Form 4: Update Filing for Gilead Sciences Inc (GILD) (VKR)
|
2013-05-15@06:40:11 ET
Form 4: Update Filing for Gilead Sciences Inc (GILD) (VKR)
|
2013-05-15@06:40:01 ET
Form 4: Update Filing for Gilead Sciences Inc (GILD) (VKR)
|
2013-05-15@06:39:51 ET
Form 4: Update Filing for Gilead Sciences Inc (GILD) (VKR)
|
2013-05-15@06:39:41 ET
Form 4: Update Filing for Gilead Sciences Inc (GILD) (VKR)
|
2013-05-14@16:05:00 ET
Gilead Sciences to Present at the Bank of America Merrill Lynch 2013 Health Care Conference on Wednesday, May 15 (BIZ)
|
2013-05-14@08:55:00 ET
Reveal Insider Trading in J.C. Penney, Gilead Sciences, Chesapeake Energy, Annaly Capital Management, Endo Health Solutions, and Zynga (PRN)
|
2013-05-14@07:19:39 ET
Australia Patent: Gilead Sciences Files Application for 'Tenofovir alafenamide hemifumarate' (ABW)
|
2013-05-13@11:03:28 ET
Buyers Accumulate Shares of Gilead Sciences, Up 2.3% (F77)
|
2013-05-11@05:43:32 ET
Form 144: Filing to Sell 846726 Shares of Gilead Sciences Inc (GILD) (VKR)
|
